The DOI matches its Crossref record.
Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis
Abstract
Objective: The presence of antibodies against cyclic citrullinated peptides has been demonstrated to precede the onset of symptoms of rheumatoid arthritis (RA) by several years. The aim of this study was to analyze antibodies against 10 citrullinated autoantigen‐derived peptides for reactivity before the onset of RA symptoms. Methods: A case–control study was conducted within the Medical Biobank of Northern Sweden. The study was performed in 409 individuals, 386 of whom donated 717 blood samples before the onset of symptoms of RA (pre‐patients). The median period of time predating the onset of RA was 7.4 years. A total of 1,305 population‐based control subjects were also studied. Antibodies to 10 citrullinated peptides, fibrinogen α573 (Fibα573), Fibα591, Fibβ36–52, Fibβ72, Fibβ74, α‐enolase (citrullinated α‐enolase peptide 1 [CEP‐1]), triple‐helical type II collagen peptide C1 (citC1 III ), filaggrin, vimentin 2–17 (Vim2–17), and Vim60–75, were analyzed using a microarray system. Results: The fluorescence intensity of antibodies against Fibβ36–52, Fibβ74, CEP‐1, citC1 III , and filaggrin was significantly increased in pre‐patients compared with controls ( P < 0.001). The levels of the earliest‐detectable antibodies (Fibα591 and Vim60–75) fluctuated over time, with only a slight increase after the onset of disease. The frequency of antibodies against Fibβ36–52, CEP‐1, and filaggrin increased gradually, reaching the highest levels before symptom onset. The frequency of a cluster of antibodies, citC1 III , Fibα573, and Fibβ74, increased only slightly before the onset of symptoms but increased prominently after disease onset. The odds ratio for the development of RA in individuals expressing both CEP‐1 and Fibβ36–52 antibodies (using data from samples obtained <3.35 years predating symptom onset) was 40.4 (95% confidence interval 19.8–82.3) compared with having either antibody alone. Conclusion: Development of an immune response toward citrullinated peptides is initially restricted but expands with time to induce a more specific response, with levels, particularly those of antibodies against CEP‐1, Fibβ36–52, and filaggrin, increasing during the predating time period closer to the onset of symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Pathogenetic insights from the treatment of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31472-1 · Cited by 1,345
224th ENMC International Workshop:
Allenbach, Y., Mammen, A. L., Benveniste, O., Stenzel, W., Allenbach, Y., Amato, A., Aussey, A., Benveniste, O., De Bleecker, J., de Groot, I., et al. (2018) · Neuromuscular Disorders · doi:10.1016/j.nmd.2017.09.016 · Cited by 582
The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting
Malmström, V., Catrina, A. I., & Klareskog, L. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.124 · Cited by 451
Self-citationRheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction
Holers, V. M., Demoruelle, M. K., Kuhn, K. A., Buckner, J. H., Robinson, W. H., Okamoto, Y., Norris, J. M., & Deane, K. D. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0070-0 · Cited by 417
Pianta, A., Arvikar, S., Strle, K., Drouin, E. E., Wang, Q., Costello, C. E., & Steere, A. C. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40003 · Cited by 402
Metadata
- Authors
- Brink, M., Hansson, M., Mathsson, L., Jakobsson, P., Holmdahl, R., Hallmans, G., Stenlund, H., Rönnelid, J., Klareskog, L., & Rantapää‐Dahlqvist, S.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2013-03-28
- Volume
- 65
- Issue
- 4
- Pages
- 899-910
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1913865297
- Cited by
- 194
- References
- 0
- FWCI
- 20.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis. https://app.cochat.ai/papers/10.1002/art.37835
- The paper
- Brink, M., Hansson, M., Mathsson, L., Jakobsson, P., Holmdahl, R., Hallmans, G., Stenlund, H., Rönnelid, J., Klareskog, L., & Rantapää‐Dahlqvist, S. (2013). Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis. Arthritis & Rheumatism. https://doi.org/10.1002/art.37835
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.